Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

  • Authors : Borisov S; Moscow Research and Clinical Center for TB Control, Moscow Government's Health Department, Moscow, Russian Federation.; These authors contributed equally.

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*adverse effects ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*diagnosis ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*epidemiology

  • Source: The European respiratory journal [Eur Respir J] 2019 Dec 19; Vol. 54 (6). Date of Electronic Publication: 2019 Dec 19 (Print Publication: 2019).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print

Record details

×
Editorial & Opinion

The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.

  • Authors : van Leth F; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.; Amsterdam University Medical Centers, Location Meibergdreef, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.

Subjects: International Cooperation*; Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*therapeutic use ; Tuberculosis, Multidrug-Resistant/Tuberculosis, Multidrug-Resistant/Tuberculosis, Multidrug-Resistant/*diagnosis

  • Source: The European respiratory journal [Eur Respir J] 2019 Jan 03; Vol. 53 (1). Date of Electronic Publication: 2019 Jan 03 (Print Publication: 2019).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print

Record details

×
Report

Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.

  • Authors : Guglielmetti L; APHP, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR-MyRMA), Bactériologie-Hygiène, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France .; Sorbonne Université, Université Pierre et Marie Curie 06, Unité 1135, Team E13 (Bactériologie), CR7 INSERM, Centre d'Immunologie et des Maladies Infectieuses, Paris, France.

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*administration & dosage ; Diarylquinolines/Diarylquinolines/Diarylquinolines/*administration & dosage ; Nitroimidazoles/Nitroimidazoles/Nitroimidazoles/*administration & dosage

  • Source: The European respiratory journal [Eur Respir J] 2018 Mar 22; Vol. 51 (3). Date of Electronic Publication: 2018 Mar 22 (Print Publication: 2018).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print

Record details

×
Editorial & Opinion

Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.

  • Authors : Kuksa L; Riga East University Hospital for TB and Lung Disease Centre, Riga, Latvia.; Barkane L

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*therapeutic use ; Extensively Drug-Resistant Tuberculosis/Extensively Drug-Resistant Tuberculosis/Extensively Drug-Resistant Tuberculosis/*drug therapy ; Nitroimidazoles/Nitroimidazoles/Nitroimidazoles/*therapeutic use

  • Source: The European respiratory journal [Eur Respir J] 2017 Nov 09; Vol. 50 (5). Date of Electronic Publication: 2017 Nov 09 (Print Publication: 2017).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print

Record details

×
Report

Treatment outcomes of MDR-TB and HIV co-infection in Europe.

Subjects: Patient Outcome Assessment*; Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*complications

  • Source: The European respiratory journal [Eur Respir J] 2017 Jun 08; Vol. 49 (6). Date of Electronic Publication: 2017 Jun 08 (Print Publication: 2017).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print

Record details

×
Academic Journal

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*therapeutic use ; Tuberculosis, Multidrug-Resistant/Tuberculosis, Multidrug-Resistant/Tuberculosis, Multidrug-Resistant/*therapy; Adult

  • Source: The European respiratory journal [Eur Respir J] 2016 Oct; Vol. 48 (4), pp. 1160-1170. Date of Electronic Publication: 2016 Sep 01.Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Print-Electronic

Record details

×
Academic Journal

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.

  • Authors : Skripconoka V; Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Riga, Latvia.; Danilovits M

Subjects: Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/*therapeutic use ; Extensively Drug-Resistant Tuberculosis/Extensively Drug-Resistant Tuberculosis/Extensively Drug-Resistant Tuberculosis/*drug therapy ; Nitroimidazoles/Nitroimidazoles/Nitroimidazoles/*therapeutic use

  • Source: The European respiratory journal [Eur Respir J] 2013 Jun; Vol. 41 (6), pp. 1393-400. Date of Electronic Publication: 2012 Sep 27.Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Print-Electronic

Record details

×
  • 1-7 of  7 results for ""Latvia""